Pasithea Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $976 |
Gross Profit | -162 | -162 | 814 | |
EBITDA | -2,842 | -3,782 | -3,878 | -4,986 |
EBIT | -3,004 | -3,945 | -4,040 | -5,148 |
Net Income | -2,999 | -3,866 | -3,860 | -5,048 |
Net Change In Cash | 0 | 0 | 0 | 976 |
Free Cash Flow | -3,120 | -4,038 | -4,321 | -3,311 |
Cash | 9,361 | 7,967 | 12,009 | 16,331 |
Basic Shares | 1,044 | 1,043 | 1,042 | 1,041 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $486 | $486 | $15 |
Gross Profit | -648 | 373 | -2 |
EBITDA | -15,330 | -12,583 | -4,506 |
EBIT | -15,979 | -12,588 | -4,507 |
Net Income | -15,961 | -13,056 | -2,174 |
Net Change In Cash | 486 | 486 | 15 |
Free Cash Flow | -12,848 | -16,700 | -3,195 |
Cash | 16,331 | 33,146 | 52,966 |
Basic Shares | 1,226 | 1,262 | 1,150 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$2.87 |
2024-06-30 | -$3.70 |
2024-03-31 | -$3.70 |
2023-12-31 | -$4.84 |
